WallStSmart

Alamar Biosciences, Inc. Common Stock (ALMR)vsGE HealthCare Technologies Inc. (GEHC)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

GE HealthCare Technologies Inc. generates 27692% more annual revenue ($20.63B vs $74.21M). GEHC leads profitability with a 10.1% profit margin vs -40.2%. GEHC earns a higher WallStSmart Score of 65/100 (C+).

ALMR

Avoid

16

out of 100

Grade: F

Growth: 6.0Profit: 2.0Value: 5.0Quality: 5.0

GEHC

Buy

65

out of 100

Grade: C+

Growth: 4.0Profit: 7.0Value: 8.0Quality: 4.3
Piotroski: 2/9Altman Z: 1.34
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for ALMR.

GEHCUndervalued (+42.6%)

Margin of Safety

+42.6%

Fair Value

$137.94

Current Price

$60.84

$77.10 discount

UndervaluedFair: $137.94Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

ALMR0 strengths · Avg: 0/10

No standout strengths identified

GEHC3 strengths · Avg: 8.3/10
Return on EquityProfitability
22.4%9/10

Every $100 of equity generates 22 in profit

P/E RatioValuation
14.3x8/10

Attractively priced relative to earnings

Price/BookValuation
2.7x8/10

Reasonable price relative to book value

Areas to Watch

ALMR4 concerns · Avg: 3.3/10
Revenue GrowthGrowth
0.0%4/10

0.0% revenue growth

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$1.67B3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-33.6%2/10

ROE of -33.6% — below average capital efficiency

GEHC3 concerns · Avg: 2.3/10
Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

EPS GrowthGrowth
-17.7%2/10

Earnings declined 17.7%

Altman Z-ScoreHealth
1.342/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : ALMR

ALMR has a balanced fundamental profile.

Bull Case : GEHC

The strongest argument for GEHC centers on Return on Equity, P/E Ratio, Price/Book. PEG of 1.41 suggests the stock is reasonably priced for its growth.

Bear Case : ALMR

The primary concerns for ALMR are Revenue Growth, EPS Growth, Market Cap.

Bear Case : GEHC

The primary concerns for GEHC are Piotroski F-Score, EPS Growth, Altman Z-Score.

Key Dynamics to Monitor

ALMR profiles as a turnaround stock while GEHC is a value play — different risk/reward profiles.

GEHC is growing revenue faster at 7.1% — sustainability is the question.

GEHC generates stronger free cash flow (917M), providing more financial flexibility.

Monitor MEDICAL DEVICES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

GEHC scores higher overall (65/100 vs 16/100). Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Alamar Biosciences, Inc. Common Stock

HEALTHCARE · MEDICAL DEVICES · USA

None

GE HealthCare Technologies Inc.

HEALTHCARE · MEDICAL DEVICES · USA

GE HealthCare Technologies Inc. provides medical technology, pharmaceutical diagnostics, and digital solutions in the United States. The company is headquartered in Chicago, Illinois.

Want to dig deeper into these stocks?